Hoppa till huvudinnehållet

Publikationer av Adil Mardinoglu

Refereegranskade

Artiklar

[1]
N. Gouleni et al., "Anticancer Potential of Novel Cinnamoyl Derivatives against U87MG and SHSY-5Y Cell Lines," Anti-Cancer Agents in Medicinal Chemistry, vol. 24, no. 1, s. 39-49, 2024.
[4]
Y. Akbaba et al., "Novel tetrahydronaphthalen-1-yl-phenethyl ureas : synthesis and dual antibacterial-anticancer activities," Journal of enzyme inhibition and medicinal chemistry (Print), vol. 39, no. 1, 2024.
[6]
J. Matić et al., "Sulfone-based human liver pyruvate kinase inhibitors – Design, synthesis and in vitro bioactivity," European Journal of Medicinal Chemistry, vol. 269, 2024.
[7]
N. Thalén et al., "Tuning of CHO secretional machinery improve activity of secreted therapeutic sulfatase 150-fold," Metabolic engineering, vol. 81, s. 157-166, 2024.
[8]
M. Laudette et al., "Cardiomyocyte-specific PCSK9 deficiency compromises mitochondrial bioenergetics and heart function," Cardiovascular Research, vol. 119, no. 7, s. 1537-1552, 2023.
[13]
[14]
[18]
B. Yulug et al., "Infection with COVID-19 is no longer a public emergency : But what about degenerative dementia?," Journal of Medical Virology, vol. 95, no. 9, 2023.
[19]
H. Turkez et al., "Lipoic Acid Conjugated Boron Hybrids Enhance Wound Healing and Antimicrobial Processes," Pharmaceutics, vol. 15, no. 1, s. 149, 2023.
[23]
M. B. Alvez et al., "Next generation pan-cancer blood proteome profiling using proximity extension assay," Nature Communications, vol. 14, no. 1, 2023.
[25]
N. Gouleni et al., "Novel styryl-thiazole hybrids as potential anti-Alzheimer's agents," RSC Medicinal Chemistry, vol. 14, no. 11, s. 2315-2326, 2023.
[29]
A. T. Ambikan et al., "Systems-level temporal immune-metabolic profile in Crimean-Congo hemorrhagic fever virus infection," Proceedings of the National Academy of Sciences of the United States of America, vol. 120, no. 37, 2023.
[30]
X. Li et al., "The acute effect of different NAD+ precursors included in the combined metabolic activators," Free Radical Biology & Medicine, vol. 205, s. 77-89, 2023.
[31]
L. Voland et al., "Tissue pleiotropic effect of biotin and prebiotic supplementation in established obesity," American Journal of Physiology. Endocrinology and Metabolism, vol. 325, no. 4, s. E390-E405, 2023.
[34]
A. Nain-Perez et al., "Anthraquinone derivatives as ADP-competitive inhibitors of liver pyruvate kinase," European Journal of Medicinal Chemistry, vol. 234, s. 114270, 2022.
[36]
R. K. Baboota et al., "BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASH," Nature Metabolism, vol. 4, no. 8, s. 1007-1021, 2022.
[38]
O. C. Yildirim et al., "Boron Nitride Nanoparticles Loaded with a Boron-Based Hybrid as a Promising Drug Carrier System for Alzheimer's Disease Treatment," International Journal of Molecular Sciences, vol. 23, no. 15, 2022.
[39]
R. K. Baboota et al., "Chronic hyperinsulinemia promotes human hepatocyte senescence," Molecular Metabolism, vol. 64, 2022.
[40]
C. Cornacchia et al., "Development of L-Dopa-containing diketopiperazines as blood-brain barrier shuttle," European Journal of Medicinal Chemistry, vol. 243, 2022.
[43]
M. Karlsson et al., "Genome-wide annotation of protein-coding genes in pig," BMC Biology, vol. 20, no. 1, 2022.
[44]
E. Mohammadi et al., "Improvement of the performance of anticancer peptides using a drug repositioning pipeline," Biotechnology Journal, vol. 17, no. 1, s. 2100417, 2022.
[46]
A. Tanas et al., "In Vitro and In Vivo Neuroprotective Effects of Sarcosine," BioMed Research International, vol. 2022, 2022.
[49]
S. Lam et al., "Machine Learning Analysis Reveals Biomarkers for the Detection of Neurological Diseases," Frontiers in Molecular Neuroscience, vol. 15, 2022.
[52]
M. Zeybel et al., "Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis," Advanced Science, vol. 9, no. 11, s. 2104373, 2022.
[54]
Z. Liu et al., "Recent Progress and Future Direction for the Application of Multiomics Data in Clinical Liver Transplantation," JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, vol. 10, no. 2, s. 363-373, 2022.
[55]
[57]
T. Basak et al., "Synthesis and in Vitro Toxicity Assessment of Different Nano-Calcium Phosphate Nanoparticles," Brazilian archives of biology and technology, vol. 65, 2022.
[58]
H. Turkez et al., "Therapeutic Potential of Ferulic Acid in Alzheimer's Disease," Current Drug Delivery, vol. 19, no. 8, s. 860-873, 2022.
[60]
C. Y. Kahraman et al., "A Novel Mutation of ATP7B Gene in a Case of Wilson Disease," Medicina, vol. 57, no. 2, 2021.
[62]
M. Karlsson et al., "A single-cell type transcriptomics map of human tissues," Science Advances, vol. 7, no. 31, 2021.
[64]
S. Lam et al., "Addressing the heterogeneity in liver diseases using biological networks," Briefings in Bioinformatics, vol. 22, no. 2, s. 1751-1766, 2021.
[65]
I. Cacciatore et al., "Boron-based hybrids as novel scaffolds for the development of drugs with neuroprotective properties," RSC Medicinal Chemistry, vol. 12, no. 11, s. 1944-1949, 2021.
[66]
Ö. Altay et al., "Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19," Advanced Science, vol. 8, no. 17, 2021.
[70]
L. Andersson et al., "Glucosylceramide synthase deficiency in the heart compromises beta 1-adrenergic receptor trafficking," European Heart Journal, vol. 42, no. 43, s. 4481-+, 2021.
[72]
H. Turkez et al., "In vitro transcriptome response to propolis in differentiated SH-SY5Y neurons," Journal of food biochemistry, vol. 45, no. 12, 2021.
[77]
S. Doran et al., "Multi-omics approaches for revealing the complexity of cardiovascular disease," Briefings in Bioinformatics, vol. 22, no. 5, 2021.
[79]
A. Yazici et al., "Potential Anticancer Effect of Carvacrol Codrugs on Human Glioblastoma Cells," Current Drug Delivery, vol. 18, no. 3, s. 350-356, 2021.
[82]
A. Bayraktar et al., "Revealing the Molecular Mechanisms of Alzheimer's Disease Based on Network Analysis," International Journal of Molecular Sciences, vol. 22, no. 21, 2021.
[85]
D. Mahdessian et al., "Spatiotemporal dissection of the cell cycle with single-cell proteogenomics," Nature, vol. 590, no. 7847, 2021.
[89]
A. Kaynar et al., "Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme," International Journal of Molecular Sciences, vol. 22, no. 24, s. 13213, 2021.
[90]
[91]
C. Y. Kahraman et al., "The Assessment of Selected miRNA Profile in Familial Mediterranean Fever," BioMed Research International, vol. 2021, 2021.
[92]
M. Arif et al., "iNetModels 2.0 : an interactive visualization and database of multi-omics data.," Nucleic Acids Research, vol. 49, no. W1, s. W271-W276, 2021.
[93]
S. Lam et al., "A systems biology approach for studying neurodegenerative diseases," Drug Discovery Today, vol. 25, no. 7, s. 1146-1159, 2020.
[96]
J. L. Robinson et al., "An atlas of human metabolism," Science Signaling, vol. 13, no. 624, 2020.
[97]
E. Sjöstedt et al., "An atlas of the protein-coding genes in the human, pig, and mouse brain," Science, vol. 367, no. 6482, s. 1090-+, 2020.
[98]
O. Özdemir et al., "Anticancer effects of novel NSAIDs derivatives on cultured human glioblastoma cells," Zeitschrift für Naturforschung C - A Journal of Biosciences, 2020.
[100]
E. C. Sayitoglu et al., "Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D," Frontiers in Immunology, vol. 11, 2020.
[102]
C. Lieven et al., "Correction: MEMOTE for standardized genome-scale metabolic model testing (vol 38, pg 272, 2020)," Nature Biotechnology, vol. 38, no. 4, s. 504-504, 2020.
[103]
[108]
[109]
T. Abdellah et al., "Integration of molecular profiles in a longitudinal wellness profiling cohort," Nature Communications, vol. 11, no. 1, 2020.
[111]
C. Lieven et al., "MEMOTE for standardized genome-scale metabolic model testing," Nature Biotechnology, vol. 38, no. 3, s. 272-276, 2020.
[113]
H. Turkez et al., "Nonpharmacological treatment options for Alzheimer's disease : from animal testing to clinical studies," Turkish Journal of Zoology, vol. 44, no. 2, s. 81-89, 2020.
[119]
M. Uhlén et al., "A genome-wide transcriptomic analysis of protein-coding genes in human blood cells," Science, vol. 366, no. 6472, s. 1471-+, 2019.
[120]
M. Klevstig et al., "Cardiac expression of the microsomal triglyceride transport protein protects the heart function during ischemia," Journal of Molecular and Cellular Cardiology, vol. 137, s. 1-8, 2019.
[126]
C. Cadenas et al., "LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer," International Journal of Cancer, vol. 145, no. 4, s. 901-915, 2019.
[131]
B. C. Turanli et al., "Systems biology based drug repositioning for development of cancer therapy," Seminars in Cancer Biology, 2019.
[133]
A. Mardinoglu et al., "The Potential Use of Metabolic Cofactors in Treatment of NAFLD," Nutrients, vol. 11, no. 7, 2019.
[134]
M. Uhlén et al., "The human secretome," Science Signaling, vol. 12, no. 609, 2019.
[135]
B. Turanli et al., "A Network-Based Cancer Drug Discovery : From Integrated Multi-Omics Approaches to Precision Medicine," Current pharmaceutical design, vol. 24, no. 32, s. 3778-3790, 2018.
[139]
B. Turanli et al., "Drug Repositioning for Effective Prostate Cancer Treatment," Frontiers in Physiology, vol. 9, 2018.
[141]
[142]
L. Zamani et al., "High Cell Density Perfusion Culture has a Maintained Exoproteome and Metabolome," Biotechnology Journal, vol. 13, no. 10, 2018.
[144]
Z. Liu, A. Mardinoglu och S. Que, "Letter : dose-response analysis revealed closer relationship between obesity and perioperative outcomes in patients after liver transplantation," Alimentary Pharmacology and Therapeutics, vol. 47, no. 2, s. 310-312, 2018.
[145]
[147]
G. Bidkhori et al., "Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes," Proceedings of the National Academy of Sciences of the United States of America, 2018.
[148]
A. Mardinoglu et al., "Systems biology in hepatology : approaches and applications," Nature Reviews. Gastroenterology & Hepatology, vol. 15, no. 6, s. 365-377, 2018.
[153]
M. Uhlén et al., "A pathology atlas of the human cancer transcriptome," Science, vol. 357, no. 6352, s. 660-+, 2017.
[154]
P. J. Thul et al., "A subcellular map of the human proteome," Science, vol. 356, no. 6340, 2017.
[155]
A. Mardinoglu och J. Boren, "AUP1 (Ancient Ubiquitous Protein 1) : A Molecular Link Between Hepatic Lipid Mobilization and VLDL Secretion," Arteriosclerosis, Thrombosis and Vascular Biology, vol. 37, no. 4, s. 609-610, 2017.
[156]
J. Bosley et al., "Improving the economics of NASH/NAFLD treatment through the use of systems biology," Drug Discovery Today, vol. 22, no. 10, s. 1532-1538, 2017.
[159]
[160]
A. Mardinoglu et al., "Plasma Mannose Levels Are Associated with Incident Type 2 Diabetes and Cardiovascular Disease," Cell Metabolism, vol. 26, no. 2, s. 281-283, 2017.
[161]
Z. Liu, S. Que och A. Mardinoglu, "Rediscussion on Linearity Between Fibrosis Stages and Mortality Risk in Nonalcoholic Fatty Liver Disease Patients," Hepatology, vol. 66, no. 4, s. 1357-1358, 2017.
[162]
P. Sen, A. Mardinogulu och J. Nielsen, "Selection of complementary foods based on optimal nutritional values," Scientific Reports, vol. 7, no. 1, 2017.
[163]
S. Lee et al., "TCSBN: a database of tissue and cancer specific biological networks," Nucleic Acids Research, vol. 46, no. D1, s. D595-D600, 2017.
[165]
J. R. Casey et al., "Adaptive Evolution of Phosphorus Metabolism in Prochlorococcus," mSystems, vol. 1, no. 6, 2016.
[166]
S. Lee et al., "Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis," Nucleic Acids Research, vol. 44, no. 12, s. 5529-5539, 2016.
[167]
A. Mardinoglu och J. Bosley, "Integrated Network Modeling for Novel Target Searches and Better Predictive Models," Journal of Pharmacokinetics and Pharmacodynamics, vol. 43, s. S88-S88, 2016.
[168]
[171]
M. Uhlén et al., "Transcriptomics resources of human tissues and organs," Molecular Systems Biology, vol. 12, no. 4, 2016.
[172]
P. Ghaffari, A. Mardinoglu och J. Nielsen, "Cancer Metabolism : A Modeling Perspective," Frontiers in Physiology, vol. 6, 2015.
[175]
A. Mardinoglu et al., "The gut microbiota modulates host amino acid and glutathione metabolism in mice," Molecular Systems Biology, vol. 11, no. 10, 2015.

Konferensbidrag

[176]
M. Jocevski et al., "Harmonized Supervision of Degree Project Work," i Scholarship of Teaching and Learning 2019, 2019.

Icke refereegranskade

Artiklar

[177]
G. Kocak et al., "On-chip platform for derivation of ocular cells from hiPSCs," Tissue Engineering. Part A, vol. 29, no. 13-14, 2023.
[178]
G. Kocak et al., "On-chip platform for derivation of ocular cells from hiPSCs," Tissue Engineering. Part A, vol. 29, no. 13-14, 2023.
[179]
H. Yang et al., "Revisiting the role of serine metabolism in hepatic lipogenesis," Nature Metabolism, vol. 5, no. 5, s. 760-761, 2023.
[182]
E. B. Emanuelsson et al., "MRI Characterization Of Skeletal Muscle Size And Fatty Infiltration In Long-term Trained And Untrained Individuals," Medicine & Science in Sports & Exercise, vol. 54, no. 9, s. 389-389, 2022.
[183]
S. M. Reitzner et al., "Metabolomic Response To Acute Endurance And Resistance Exercise In Life-long Trained Athletes And Untrained Individuals," Medicine & Science in Sports & Exercise, vol. 54, no. 9, s. 628-628, 2022.
[184]
M. Chapman et al., "Skeletal Muscle Proteomics Comparison Between Long-term Trained And Untrained Men And Women," Medicine & Science in Sports & Exercise, vol. 54, no. 9, s. 392-393, 2022.
[185]
[187]
M. Sinha et al., "Editorial : Redox Homeostasis and Cancer," Oxidative Medicine and Cellular Longevity, vol. 2020, 2020.
[189]
A. Mardinoglu, M. Uhlen och J. Boren, "Broad Views of Non-alcoholic Fatty Liver Disease," CELL SYSTEMS, vol. 6, no. 1, s. 7-9, 2018.
[190]
J. Cao et al., "Principles of Systems Biology, No. 21," CELL SYSTEMS, vol. 5, no. 3, s. 158-160, 2017.
[191]
A. Mardinoglu, J. Boren och U. Smith, "Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes," Cell Metabolism, vol. 23, no. 1, s. 10-12, 2016.
[192]
A. Mardinoglu och J. Nielsen, "Editorial : The Impact of Systems Medicine on Human Health and Disease," Frontiers in Physiology, vol. 7, 2016.

Kapitel i böcker

[193]
H. Türkez, M. E. Arslan och A. Mardinoglu, "Pivotal role of micronucleus test in drug discovery," i Micronucleus Assay : An Overview, : Nova Science Publishers, Inc., 2019, s. 49-73.
Senaste synkning med DiVA:
2024-03-29 00:31:07